The neurological disorders sector is witnessing unprecedented transformation, with Alzheimer's disease emerging as a pivotal focus area for global healthcare systems. This devastating neurodegenerative condition continues to challenge medical professionals, researchers, and pharmaceutical companies worldwide, creating significant opportunities and complexities within the...

The Alzheimer’s Disease Drugs Market is experiencing a pivotal transformation. Following decades marked by high attrition rates and late-stage clinical failures, the period between 2023 and 2025 witnessed the first widely recognized successes in disease-modifying therapies (DMTs). These breakthroughs are reshaping both clinical practice and commercial strategies. Coupled with aging...